Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
- 1 March 1999
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (4) , 924-931
- https://doi.org/10.1016/s0735-1097(98)00680-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart DiseasePublished by Elsevier ,1998
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart FailureCirculation, 1995
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1994
- Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trialJournal of the American College of Cardiology, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADEThe Lancet, 1979
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975